These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28992939)

  • 1. Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease.
    Yang C; Kwak L; Ballew SH; Garimella PS; Jaar BG; Folsom AR; Heiss G; Selvin E; Lutsey PL; Coresh J; Matsushita K
    Atherosclerosis; 2017 Dec; 267():167-174. PubMed ID: 28992939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study.
    Menez S; Ding N; Grams ME; Lutsey PL; Heiss G; Folsom AR; Selvin E; Coresh J; Jaar BG; Matsushita K
    Nephrol Dial Transplant; 2020 Nov; 35(11):1878-1885. PubMed ID: 32191294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Jaar BG; Rebholz CM; Grams ME; Michos ED; Wolf M; Kovesdy CP; Uchida S; Coresh J; Lutsey PL; Matsushita K
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4648-4657. PubMed ID: 29029099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.
    Astor BC; Shafi T; Hoogeveen RC; Matsushita K; Ballantyne CM; Inker LA; Coresh J
    Am J Kidney Dis; 2012 May; 59(5):653-62. PubMed ID: 22305758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in novel filtration markers and risk of ESRD.
    Rebholz CM; Grams ME; Matsushita K; Selvin E; Coresh J
    Am J Kidney Dis; 2015 Jul; 66(1):47-54. PubMed ID: 25542414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.
    Huang M; Matsushita K; Sang Y; Ballew SH; Astor BC; Coresh J
    Am J Kidney Dis; 2015 Jan; 65(1):58-66. PubMed ID: 25151408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney function, bone-mineral metabolism markers, and calcification of coronary arteries, aorta, and cardiac valves in older adults.
    Mok Y; Wang F; Ballew SH; Menez S; Butler KR; Wagenknecht L; Sedaghat S; Lutsey PL; Coresh J; Blaha MJ; Matsushita K
    Atherosclerosis; 2023 Mar; 368():35-43. PubMed ID: 36754659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.
    Rebholz CM; Grams ME; Matsushita K; Inker LA; Foster MC; Levey AS; Selvin E; Coresh J
    Clin J Am Soc Nephrol; 2015 Jun; 10(6):941-8. PubMed ID: 25825481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease.
    Joosten MM; Pai JK; Bertoia ML; Gansevoort RT; Bakker SJ; Cooke JP; Rimm EB; Mukamal KJ
    J Am Heart Assoc; 2014 Jun; 3(4):. PubMed ID: 24980133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney function and sudden cardiac death in the community: The Atherosclerosis Risk in Communities (ARIC) Study.
    Suzuki T; Agarwal SK; Deo R; Sotoodehnia N; Grams ME; Selvin E; Calkins H; Rosamond W; Tomaselli G; Coresh J; Matsushita K
    Am Heart J; 2016 Oct; 180():46-53. PubMed ID: 27659882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002.
    Selvin E; Köttgen A; Coresh J
    Eur Heart J; 2009 Aug; 30(15):1918-25. PubMed ID: 19487236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFR Estimation Using β-Trace Protein and β2-Microglobulin in CKD.
    Inker LA; Tighiouart H; Coresh J; Foster MC; Anderson AH; Beck GJ; Contreras G; Greene T; Karger AB; Kusek JW; Lash J; Lewis J; Schelling JR; Navaneethan SD; Sondheimer J; Shafi T; Levey AS
    Am J Kidney Dis; 2016 Jan; 67(1):40-8. PubMed ID: 26362696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in the Elderly: AGES-Kidney and MESA-Kidney.
    Foster MC; Levey AS; Inker LA; Shafi T; Fan L; Gudnason V; Katz R; Mitchell GF; Okparavero A; Palsson R; Post WS; Shlipak MG
    Am J Kidney Dis; 2017 Sep; 70(3):406-414. PubMed ID: 28549536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.
    Daya N; Voskertchian A; Schneider ALC; Ballew S; McAdams DeMarco M; Coresh J; Appel LJ; Selvin E; Grams ME
    Am J Kidney Dis; 2016 Feb; 67(2):218-226. PubMed ID: 26250781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-23 and the long-term risk of hospital-associated AKI among community-dwelling older individuals.
    Brown JR; Katz R; Ix JH; de Boer IH; Siscovick DS; Grams ME; Shlipak M; Sarnak MJ
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):239-46. PubMed ID: 24262510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD.
    Liu X; Foster MC; Tighiouart H; Anderson AH; Beck GJ; Contreras G; Coresh J; Eckfeldt JH; Feldman HI; Greene T; Hamm LL; He J; Horwitz E; Lewis J; Ricardo AC; Shou H; Townsend RR; Weir MR; Inker LA; Levey AS;
    Am J Kidney Dis; 2016 Dec; 68(6):892-900. PubMed ID: 27663042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
    Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
    Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study.
    Scheppach JB; Coresh J; Wu A; Gottesman RF; Mosley TH; Knopman DS; Grams ME; Sharrett AR; Koton S
    Am J Kidney Dis; 2020 Dec; 76(6):775-783. PubMed ID: 32428540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast Growth Factor 23: A Biomarker of Kidney Function Decline.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak MG; Newman AB; Hoofnagle A; Fried L; Sarnak MJ; Gutierrez OM
    Am J Nephrol; 2018; 47(4):242-250. PubMed ID: 29621752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated GFR and risk of hip fracture in older men: comparison of associations using cystatin C and creatinine.
    Ensrud KE; Parimi N; Fink HA; Ishani A; Taylor BC; Steffes M; Cauley JA; Lewis CE; Orwoll ES;
    Am J Kidney Dis; 2014 Jan; 63(1):31-9. PubMed ID: 23890927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.